These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20067463)

  • 21. Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.
    Filippou PS; Ren AH; Bala S; Papaioannou MD; Brinc D; Prassas I; Karakosta T; Diamandis EP
    Clin Biochem; 2018 Aug; 58():108-115. PubMed ID: 29928903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer disease.
    Christoph F; König F; Lebentrau S; Jandrig B; Krause H; Strenziok R; Schostak M
    World J Urol; 2018 Feb; 36(2):187-192. PubMed ID: 29204705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.
    Luo J; Dunn T; Ewing C; Sauvageot J; Chen Y; Trent J; Isaacs W
    Prostate; 2002 May; 51(3):189-200. PubMed ID: 11967953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
    Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
    Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
    Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
    Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
    Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
    Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Ma W; Zeng G; Qi D
    J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
    Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
    J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
    Fawzy MS; Mohamed RH; Elfayoumi AR
    Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the plasma level of long non-coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients.
    Rezatabar S; Moudi E; Sadeghi F; Khafri S; Kopi TA; Parsian H
    J Gene Med; 2020 Oct; 22(10):e3239. PubMed ID: 32529802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer.
    Pang C; Liu M; Fang W; Guo J; Zhang Z; Wu P; Zhang Y; Wang J
    Cell Physiol Biochem; 2016; 39(3):1111-7. PubMed ID: 27562849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
    Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
    Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
    Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
    Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
    Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
    Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.
    Love HD; Booton SE; Boone BE; Breyer JP; Koyama T; Revelo MP; Shappell SB; Smith JR; Hayward SW
    PLoS One; 2009 Dec; 4(12):e8384. PubMed ID: 20027305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMP26: A potential biomarker for prostate cancer.
    Cheng T; Li F; Wei R; Lv MQ; Zhou Y; Dai Y; Yuan Y; Jiang GY; Ma D; Gao QL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):891-894. PubMed ID: 29270749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.
    Stamey TA; Warrington JA; Caldwell MC; Chen Z; Fan Z; Mahadevappa M; McNeal JE; Nolley R; Zhang Z
    J Urol; 2001 Dec; 166(6):2171-7. PubMed ID: 11696729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
    Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
    Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.